Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current assets:
Cash	$ 236,597	$ 90,192
Accounts receivable, net	60,000	0
Inventory	247,433	202,077
Deferred debt issuance costs	82,227	165,649
Prepaid expenses and other current assets	174,852	191,030
Total current assets	801,109	648,948
Fixed assets, net	15,917	85,592
Patents, net	1,513,340	1,678,787
TOTAL ASSETS	2,330,366	2,413,327
Current liabilities:
Accounts payable	1,009,018	861,698
Note payable to an affiliate	30,000	0
Convertible debt, net of discounts of $644,518 as of December 31, 2013 and $520,851 as of December 31, 2012	2,307,111	608,622
Derivative liability	1,104,423	2,335,560
Accrued Expenses	431,045	183,855
Total current liabilities	4,881,597	3,989,735
COMMITMENTS AND CONTINGENCIES
Stockholders' deficit
Common stock, $.01 par value; 321,415,000 shares authorized; 166,712,054 and 152,229,665 shares issued and outstanding as of December 31, 2013 and December 31, 2012	1,667,120	1,522,297
Additional paid in capital	37,126,602	35,491,603
Accumulated deficit	(41,375,803)	(38,626,158)
Total stockholders' deficit	(2,551,231)	(1,576,408)
TOTAL LIABILITIES AND SHAREHOLDERS' (DEFICIT)	2,330,366	2,413,327
Series A Convertible Preferred Stock
Stockholders' deficit
Convertible Preferred Stock, value	0	0
Series B Convertible Preferred Stock
Stockholders' deficit
Convertible Preferred Stock, value	25,850	25,850
Total stockholders' deficit	25,850	25,850
Series C Convertible Preferred Stock
Stockholders' deficit
Convertible Preferred Stock, value	5,000	10,000
Total stockholders' deficit	$ 5,000	$ 10,000